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ABSTRACT

EFFECTS OF DIET ARY CORN OIL AND MENHADEN OIL ON RAT
MAMMARY TUMORIGENESIS AND PROSTAGLANDIN E2 LEVELS

Melissa L. Philley
Morehead State University, 1 988

Director of Thesis:

Promotion of mammary tumors by dietary lipids has been
established by experimental and epidemiological
Menhaden oil,

a fish oil,

research.

however, has been shown to have an

inhibitory effect upon mammary tumorigenesis in rodent models.
This inhibition may be attributed to the biochemical effects of the
omega-3 fatty acids in menhaden oil as opposed to the omega-6
fatty acids of corn oil, a known promoter of mammary tumors.
This study was undertaken to evaluate the effects of
different levels of dietary menhaden oil (MO) and corn oil (CO) on
tumorigenesis and prostaglandin (PG) levels.

At 50 days of age,

120 female Sprague-Dawley rats were given 10 mg of 7,12dimethylbenz(a)anthracene by gastric intubation.
were assigned to one of six isocaloric diets:

iii

Twenty rats

1) 3.9% CO, 2) 3.9%

MO, 3) 19.4% CO, 4) 19.4% MO, 5) 15.5 % C0:3.9 %. MO, and 6) 15.5 %
M0:3.9% CO. The animals were sacrificed on day 127.
Results showed that the 3.9% MO diet was not inhibitory to
tumorigenesis.

However, rats fed diets containing 19.4% MO

exhibited lower tumor burden, less rapid tumor growth and lower
tumor PGE2 levels. When rats fed high menhaden oil 05.5%) were
supplemented with 3.9% corn oil, tumor inhibition was abolished
even though the total lipid levels were the same. Body weights
and tumor data of rats on this diet (15.5% M0:3.9% CO) were nonsignificantly elevated when compared to all other groups.

The

only rats significantly inhibited in all evaluations were those fed
high menhaden oil.
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INTRODUCTION

In the United States one of ten women develop breast
cancer, the most frequent cause of death among women ( 1 ).
There is also evidence of the importance of the early- onset of
puberty in increasing the risk of breast cancer.

Other risks

include the family history of the disease, nulliparity, as well as
first child after age thirty (2). However, dietary influences have
long been suspecte_d as an important cause of breast cancer (3).
Epidemiological and laboratory studies suggest a positive
correlation between dietary fat intake and cancer of the breast,
colon, and prostate (4 ).

Diet and Cancer

In experimental animals, both the amount and type of fat
in the diet have been shown to influence development of
carcinoma of breast, colon, and prostate (5).

Some evidence

suggests that saturated fat may influence the initiation stage of
mammary tumorigenesis and that polyunsaturated fatty acids act
on the promotional phase ( 2,6 ).

Initiation, an early and

irreversible stage in the carcinogenic process, is produced by a
single or very limited application of_ a carcinogen.

Promotion is

the stimulation of development frcim an initiated cell to a tumor.
1

2

Some dietary modifications have been shown to be capable
of altering eacp. stage of tumor development (2).
with rats and mice have shown

Many studies

that unsaturated fats, mainly

those in the linoleic family, are the most effective in the
enhancement

of

tumorigenesis (6,7).

the

promotional

phase

of

mammary

In 1985, Ip et al. observed that mammary

tumor development appeared to increase in a step-wise fashion
with increasing fatty acid levels in the diet up to 4.4%. Increases
in fatty acids above this level appear to have minimal effects (7).
A number of mechanisms have been proposed to explain the
enhancement of mammary neoplasia. These include:
( 1)

suppression of immune responses,

(2)

inhibition of intercellular communication,

(3)

increase in secretion of mammotropic hormones,

(4)

alteration of membrane structure and properties, and

(5)

increase in production of cyclooxygenase products of
arachidonic acid (8).

Vegetable oils, such as corn oil, contains high levels of
lenoleic acid (18:2n-6), the precursor of arachidonic acid (20:4n-6)
and ultimately dienoic eicosanoids or prostaglandins of the 2series (9 ).

These dienoic eicosanoids have been implicated by

several investigators as the stimulator of the promotional phase of
mammary tumorigenesis (10).
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7, 12- dimethylbenz(alanthracene (DMBA)

DMBA (Figure 1) is a synthetic polycyclic

aromatic

hydrocarbon (PAH) commonly used in the initiation of the rat
mammary tumors.

Figure 1. The structure of DMBA.

Taken from Huggins (11).

DMBA works consistently and rapidly in a single 10milligram dose ( 12 ).

Huggins reported that

after a single 20-

milligram dose of 7.12-DMBA, the maximum number of mammary
tumors ob served in a rat was 21 ( 13 ). Certain conditions under
which mammary cancers are initiated by DMBA include the
nature of the hydrocarbon, dosage, species of the rat, strain, age,
and hormonal status of the rat ( 13 ).

Huggins discovered that

mammary tumors induced by DMBA in female Sprague-Dawley
rats are similar to human breast tumors in that they are easily

4

palpable and hor mane responsive.

Also, since they do not

metastasize to new tumor sites, the DMBA-induced model is useful
in experimentation. ( 13).

The effectiveness of· DMBA as an

initiator of tu morigenesis is illustrated in Table I.

Mammary

tumors, primarily adenocarcinomas consist of mammary acini
lined with many layers of epithelial cells arranged to form glandlike structures with papillary projections. This type of tumor can
occur from neck to perineum and usually cause death through
hemorrhage, necrosis, and ulceration due to enormous size rather
than metatasis ( 11 ).

Table I. Incidence of neoplasms in rats fed DMBA. Taken from
Huggins ( 11 ).

TUMORS
Mammary cancer
Fibroadenoma

PERCENT
100
89

Leukemia

3

Ear duct cancer

s

Carcinogens can be divided into two classes based on the
electrophilic hypothesis of carcinogenesis, which states that most,
if not all, chemical carcinogens are metabolized to biologically
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reactive electrophils that exert their carcinogenic activity (2 ).
DMBA is taken up by the liver, metabolized, and excreted into the
bile or exported.

Mammary tissue can metabolize DMBA to a

slight extent. DMBA is primarily metabolized by the oxidation of
the methyl groups and, less completely, by the ring structure ( 11 ).
The main electrophilic intermediates, the bay-region of
syn- and anti-3,4-dihydrodiol-1,2 epoxides, are

thought to bind

to DNA to exert carcinogenic activity (15). These epoxides bind
covalently to deoxyadenosine and deoxyguanosine residues of
DNA (15).
In 1971, researchers discovered that DMBA

bound

preferentially to the number one chromosone in rats and was
expressed in the late interphase and prophase of the cell cycle
( 11 ). Within 24 hours of injection with DMBA, one half of the cells
in metaphase in bone marrow had chromosomes with breaks and
gaps ( 11).

Essential Fatty Acids

Dietary polyunsaturated fatty acids are the only source of
essential fatty acids (EFA) required by man and other mammals.
EFA covers a wide range of 18-, 20-, and 22-carbon chain length
polyunsaturated fatty acids (PUFA) with 2 to 6 methylene
interrupted double bonds with the cis configuration.

Neither of
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the two classes, the linoleic (omega-6) and linolenic ( omega-3 ),
can be synthesized by mammalian organisms (16). There are two
main EFAs that are manufactured by plants and not by mammalsthe cis:cis-linoleic acid (18 :2 n-6) and the cis:cis:cis-alpha-Iinolenic
acids (18:3 n-3).

These are metabolized in the body as shown in

Figure 2. EFAs of the n-6 and n-3 type appear to compete for the
same

enzyme systems, with the n-3

compounds

being

preferentially metabolized ( 17). In order for a fatty acid to have
EFA activity, all its double bonds must be in the cis configuration.
Even one bond in the trans form leads to loss of EFA activity and
to competitive inhibition of the metabolism of all cis EFAs. Many
commercially available oils contain substantial amounts of trans
acids and the factor should be taken into account ( 17).
The parent EFA can undergo chain

elongation

and

desaturation to produce long-chain derivatives of 20- and 22carbons with 3 to 6 double bonds ( 16).

As seen in Figure 2,

linoleic acid is desaturated to form gamma-linoleic acid which is,
in turn, elongated to give rise to dihomogammalinoleic acid, the
precursor of the series one prostaglandins (PGE 1 and PGE 1 alpha).
Dihomogammalinoleic acid can be desaturated also to arachidonic
acid, the precursor of the series two prostaglandins (PGE2 and
PGE2 alpha), thromboxanes and leukotrienes.

Of the omega-3

fatty acids, alpha linolenic acid is desaturated_ and elongated to
create eicosapentaenoic acid (EPA), the precursor of the series

Linoleic

n-6 EFAs

n-3 EFAs

18:2n-6

l8:3n-3

1

delta-6-desaturase

18:3n-6

l8:4n-3

Dihomogamrnalinolenic (DGLA)

20:3n-6

20:4n-3
delta-5-desaturase

l

Arachidonic (AA)

20:4n-6

20:Sn-3

Adrenic

22:4n-6

22:Sn-3

1

22:Sn-6

delta-4-desaturase

Alpha-linolenic

l

22:6n-3

II

I/

l

Gamrna-linolenic

l

I·''

Eicosapentaenoic (EPA)

Oocosahexaenoic (DHE)

Figure 2. Metabolism of two main dietary EFAs, linoleic acid
(18:3n-6) and linolenic acid ( l 8:3n-3 ). Taken from Reddy(l 7).
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three prostaglandins (PGE3 and PGE3 alpha).

EPA is further

converted to docosahexaenoic acid (DHA).

The resulting fatty

acids are fuctional components of cell

membranes. They

determine

membrane fluidity and flexiblity and

modulate

permeability and the functioning of membrane-bound enzymes
and receptors (17).
Because of their polyunsaturation, the EFAs are susceptible
to oxygen attack with the formation of peroxidized fatty acids
which are highly toxic and may be involved in the metabolic
activation of carcinogens. Peroxides may be formed from EFAs
prior to consumption or within the body itself.

Animals have

developed complex mechanisms for protecting themselves against
peroxides, both by reducing formation and increasing removal of
them ( 17).
Essential fatty acids are essential nutrients that play a
major role in the normal development of the mammary glands
and are also constituents of all cell membranes ( 18 ). Therefore, it

is possible that malignant tumors derived from mammary glands
require EFAs for growth and as with any essential nutrient, it will
be possible to demonstrate that deprivation of EFAs will inhibit
tumor growth and that provision of the nutrients will stimulate
growth ( 17). Animal studies done by Ip et al. sugggest that 1 to
2% of the total calories in the form of linoleic acid is the minimum
required to prevent EFA deficiency and

that

mammary

9

development in rodents may fail at EFA levels which do not
maintain normal growth.

This _suggests that more linoleic acid,

about a minimum of approximately 4% of total calorie intake, may
be required for the mammary gland (7).
The main conclusions from Cohen's series of studies
involving animal mammary tumors and essential fatty acids are:
1) Animals on a high-fat diet develop more tumors earlier
than animal on a low-fat diet.
2) Animals on a EFA-deficient diet have a reduced risk of
tumor formation.
3)

The fat effect is not related to any action on the

absorption of lipid-soluble carcinogen (DMBA) or on its uptake
into mammary tissue.
4)

A certain minimum level of EFA intake is required for

maximum tumor development.

About 2 to 3% of total caloric

intake as EFAs seems to be the critical figure. Provided that this
is present in the diet, high intakes of any type of fat, saturated,
monounsaturated, and polyunsaturated are effective in further
increasing tumor growth. Either n-6 or n-3 EFAs seem to be able
to fulfill the minimum requirement.

Since n-3 EFAs inhibit

prostaglandin formation from arachidonic acid, this argues
against prostaglandin formation being critical.
5) Administering a high-fat intake.prior to the carcinogen
with a normal or low-fat intake afterwards seems to have no

I0

effect on tumor growth.
DMBA, adding fat

In contrast, many weeks after giving

or withdrawing it from the diet is able to

modulate tumor growth.
6) And as an exception to the rule that fatty acids promote
tumorigenesis, rapeseed oil, which contains erucic acid, can inhibit
the conversion of linoleic acid to arachidonic acid and it inhibits
the lipoxygenase enzyme which converts PUFAs to hydroxy-acids
and Jeukotrienes ( 17).

Menhaden oil

Fish oils contain high concentrations of omega-3 fatty
acids. Current interest in omega-3 fatty acids has been spawned
from the observations that despite their high-fat, high cholesterol,
low carbohydrate

diet,

Greenland

Eskimos

rarely die of

cardiovascular disease and Alaskians have a I 0.3% death rate due
to cardiovascular disease whereas approximately 50% of all deaths
in the mainland United States are due to cardiovascular disease.
These omega-3 fatty acids of interest are eicosapentaenoic (EPA)
and docosahexaenoic (DHA) acids.
exclusively in seafood ( 19).

They are found almost

Whereas corn oil, with its main

constit'uent of linoleic acid, has been shown to greatly enhance
tumorigenesis

(2-7,14,17,18), several recent studies have

demonstrated the inhibition of menhaden or fish oil on DMBA-
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induced mammary cancer (8,9, 16,20) and in transplanted
mammary tumors (21-23).

Table 2 taken from Abou-El-Ela et al.

illustrates the fatty acid components of both corn oil and
menhaden oil (9).

Table 2. Fatty Acid Composition of Oils (%) (9).

Fatty acid

14:0
16:0
16: 1
16:2
16.3
16:4
18:0
18: 1
18:2n-6
18:3n-6
18:3n-3
18:4
20:1
20:4n-6
20:5n-3
22:5
22:6n-3
others

Corn oil

11.2

2.1
25.0
59.9
0.5

0.1

Menhaden oil

8.35
15.17
11.62
2.37
1.96
1.73
2.67
9.50
1.81
1.82
3.47
1.32
2.30
16.03
3.92
10.83
4.37
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In 1984, Kar mali et al.. used a MaxEPA marine oil to test
the effect of omega-3 fatty acids on transplanted
tumors (20).

mammary

They concluded that EPA and DHA replace the

omega-6 fatty acids in the tissue lipid, plasma, and platelets
membranes of their experimential animals, and that EPA and DHA
should limit the synthesis of the 2-series of prostaglandins. These
results suggested that the mechanism underlying tumor growth
may be linked to arachidonic acid metabolism and may be similar
to the effect of EPA and DHA in lowering platelet responsiveness
in the Eskimos.

They surmised that omega-3 fatty acids may

exert their effects by competing with arachidonic acid for the
cyclooxygenase enzyme, thereby reducing the synthesis of
prostaglandin E2 from arachidonic acid (20).
A study by Jurkowski and Cave in 1986 showed that while
a 20% dietary fat level was effective in reducing tumor
development, this was less apparent in 0.5% and 3% ·dietary fat
level (22).

Also, the animals given a diet of 0.5% menhaden oil

developed more tumors than the 0.5% corn oil control group.
The following year, Gabor and Abraham experimented
with mixed diets of menhaden and corn oil (21). They observed
that a diet of 10% menhaden oil and a mixed diet of 9% mehaden
and 1 % corn oil were effective in inhibiting tumorigenesis, while a
mixed diet of 7.5% menhaden oil and 2.5 % corn oil was not
effective in significantly inhibiting tumorigenesis.
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Menhaden oil has also been shown to inhibit NMU-induced
mammary tumors (22), L-azaserine-induced preneoplastic lesions
in

rat

pancreas

(24),

IX

transplantable

mammary

adenocarcinomas (23), azomethane-induced colon tumors (25),
and lung tumors (26).

Current evidence suggests that further

efforts are needed to establish the optimal dietary ratios of
omega-3 and omega-6 fatty acids and the actual mechanism of
action.

Prostaglandin E2

Prostaglandin is a term applied to a series of compounds
derived enzymatically and nonenzymatically from twenty carbon

fatty acids such as arachidonic acid and eicosahexaenoic acid.
Research over the past twenty years has identified prostaglandins
as products of almost every cell, although the amount and class of
prostaglandin produced varies with cell type (27).

The dienpic

eicosanoids are formed from arachidonic acid which can be
obtained only from dietary sources of omega-6 EFA (Figure 3). In
normal mammary fat pads, levels of PGE2 (Figure 4) we·re not
changed by increasing linoleate content of diet (9 ).

The

production and secretion of arachidonic products, particularly
PGE2, is increased several fold in a large number of animal
and human (28, 29) tumors.

(9)
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W-6 Family

w-3 Family

Cl8:2
linoleic
.!16 desaturase

Cl8:3
CX-linolenic

l

1

Cl8:3
Y- linolenic
elongase

l

C2O:3
dihomo- Y-linolenic
ll 5 desaturase

Cl8-4
octadecatetraenoic

j
series PGs
2 series l Ts

l
C2O:4
arachidonic
elongase

2 series PGs
4 series LTs
OH fatty acids

l

C22:4
docosatetraenoic

j
C22:5
docosapentaenoic

3 series PGs
5 series LTs
OH fatty acids

C2O:4
eicosatetraenoic

l

C2O:5
eicosapentaenoic

l
C22:5
docosapentaenoic

l

C22:6
docosahexaenoic

Figure 3. Formation of Eicosanoids. Taken from Karmali (8).
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Further support for
mammary

tumorigenesis

the

prostaglandin-high-fat-diet-

hypothesis

comes from

reports

suggesting that prostaglandin inhibitors such as indomethacin are
effective in suppressing mammary tumorgenesis in rats fed diets
high in unsaturated fatty acids. Indomethacin works by inhibiting
the cyclooxygenase component of the prostaglandin synthetase
enzyme system (10).
Along with the inhibitory effect on mammary

tumor

growth, diets rich with fish oil may also be able to control tumor
cell metastasis.

EPA and DHA have the ability to alter platelet

function though the reduction of thromboxane A2 synthesis and
by these means can possibly interfere with tumor cell platelet
interaction, an important mechanism in tumor cell metastasis (31 ).
However, when analyzing prostaglandins it is essential to
process tumors as soon as possible due to· the !ability of the
enzymes associated with

prostaglandin synthesis.

Substantial

amounts of prostaglandins may be generated in response to
trauma and variation in degree of tissue trauma might be
expected to be associated with differences in prostaglandin levels
(28).
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Figure 4. Structure of prostaglandin E2. Taken from Martin (30).

Research Objectives

In this study, the effects of dietary menhaden oil, rich in
omega-3 fatty acids, were studied on tumor incidence, tumor
number, tumor burden per tumor bearing rat, and tumor PGE2
levels.

High- and low-fat diets as well as mixed diets of

menhaden and corn oil were compared. It was hypothesized that
rats fed a high-fat diet of menhaden oil would show a decreased
tumor incidence, tumor number, tumor burden, and PGE2 levels
when compared to high-fat corn oil. The effect of mixed diets on
tumorigenesis is controversial and preliminary effects are
unknown (9,22-24).

MATERIALS AND METHODS

Animal Treatment

One hundred and twenty female Sprague-Dawley rats, 36
to 40 days of age, were obtained from Harlen Sprague-Dawley
Inc., Indianapolis, Indiana. The rats were housed in stainless steel
cages, one per cage, in a temperature- and light-controlled room
( 141: 1OD). Food and water were given ad libitum. At 50 days of
age, each animal was lightly etherized and given a 10-milligram
dose of DMBA in 1 ml of corn oil by intragastric intubation.
Twenty rats were then assigned to one of six groups: 1) 3.9% corn
oil (3.9%C0), 2) 3.9% menhaden oil (3.9%MO), 3) 19.4% corn oil
( 19.4%CO), 4) 19.4% menhaden oil ( 19.4%MO), 5) 15.5% corn oil &
3.9% menhaden oil (15.5%C0:3.9%MO), and (6) 15.5 % menhaden
oil & 3.9% corn oil ( 15.5%MO:3.9%CO). These percentages reflect
low and high concentrations of lipids. The components of all diets
were expressed in percentage by weight and all diets were
isocaloric (Table 3).
kilocalories per gram.

All diets were prepared to contain 3.51
The casein, cellulose, minerals, vitamins,

methionine, choline, and menhaden oil were purchased from
United States Biochemical Corporation, Cleveland, Ohio.
sucrose and corn oil were purchased locally.

One rat in the 3.9%

corn-oil group died in the ninth week due to unrelated causes.
17

The
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Five weeks following initiation, all rats were palpated
weekly for tumor growth. At day 77, all rats were sacrificed by
decapitation and their total number of tumors measured in three

dimensions with calipers. Tumor position and dimensions were
recorded on a rat diagram.
Each tumor from each tumor-bearing rat was dissected,
placed in polypropylene tubes containing 0.5 milliliters of
indomethacin at a concentration of 10 micrograms per milliliter
(31 ).

The tumors were then frozen in a mixture of dry ice and

acetone and stored at -20 degrees Celsius.

Table 3.

Diet concentrations by percentage.

HIGH FAT DIET

LOW FAT DIET

Casein

21.6%

21.7%

Sucrose

21.9 %

57.0%

Oil

19.4%

3.9%

Cellulose

31.8%

12.1 %

Minerals

3.8%

3.8%

Vitamins

1.0%

1.0%

Methionine

0.3%

0.3%

Choline

0.2%

0.2%

COMPONENT
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PGE2 Extraction and Determination
PGE2 extraction was performed according to the procedure
of Abou-El-Ela et al. (9). Tumors were finely minced at 4 to 6
degrees Celsius and placed in Krebs Ringer Bicarbonate Glucose
solution in a concentration of 1 gram per 5 milliliters. They were
then incubated of 37 degrees Celsius for one hour in 95%
oxygen/5% carbon dioxide environment. The tumor samples were
homogenized for 15 seconds at 8 amperes with a Branson sonifier
(Branson Instruments Inc., Stanford, CT) and acidified to a pH 3
with 0.8M phosphoric acid.

The prostaglandins were extracted

with four volumes of ethyl acetate with .vigorous shaking.

The

organic phase was removed and 50 microliters of 0.!M Tris HC!
buffer (pH 7.5) was added.

The organic phase was then

evaporated under nitrogen and the residue was reconstituted with
an appropriate aliquot of assay buffer (9). PGE2 concentrations
were determined using a prostaglandin E2 [125 I] RIA kit (Dupont
Biomedical Products, Boston, Massachusetts).

Antiserum and

radioactive tracer were added to each sample and these were
incubated for 16 to 24 hours at 2 to 8 degrees Celsius. Following
the appropriate time, the precipitating reagent was added and the
samples were centrifuged at I 000 to 20 00 x g at 4 to 6 degrees
Celsius.

The excess fluid from each tube was removed and the

tubes inverted for one minute prior to a one-minute count in a
gamma counter.
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Statistical Analysis
Analysis of variance and Duncan's multiple range test were
used to determine the significance of the results at p< .05.

RESULTS AND DISCUSSION

Each group, except 19.4% menhaden oil, developed tumors
by the end of the fifth week (Table 4). Only one tumor in the
19.4% menhaden oil group was found and not until the time of
autopsy. High concentrations of menhaden oil ( 19.4%) also greatly
reduced the percentage of rats with tumors in comparison to the
other groups. However, more than half of the rats receiving 3.9%
menhaden oil developed tumors. This suggests that low levels of
fish oil do not inhibit tumorigenesis.

Since 60% of the rats

receiving diets of 15.5% menhaden oil and 3.9% corn oil were
tumor positive, high levels of the menhaden oil mixed with low
levels of corn oil also were not inhibitory.

This suggests that

minimal levels of corn oil mixed with high levels of menhaden oil
eliminated the tumor inhibition by the fish oil alone even though
the percentage of lipids was the same in both diets.
A comparison of body weights at death can be seen in
Table 5. Rats in the 19.4% menhaden oil had body weights that
were significantly lower than all groups.

Also, rats on diets of

3. 9 % CO, 3. 9 % MO, and 19 .4 % CO had body weights that were
significantly reduced compared to the 15.5%MO:3.9%CO group.
This addition of 3.9% corn oil to the diets significantly elevated the
body weights compared to the rats receiving 19.4% menhaden oil
alone. O'Conner et al. states that while a decrease rate of body
21
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weight gain is associated with decreased tumor development, it is
erroneous to think that the associated weight development is the
single cause for decreased tumorigenesis when the diet causes a
rich diversity of other physiological and biochemical effects (24).
Table 4.
Comparison between groups, percentage of rats with
tumors and first day of tumor occurrence in relation to palpation
schedule.

GROUP

PERCENTAGE

FIRST DAY OF OCCURRENCE

3.9%CO

42%

41

3.9%MO

55%

41

19.4%CO

35%

41

5%

77

15.5%CO:3.9%MO

45%

41

15.5%MO:3.9%CO

60%

41

19.4%MO

Analysis of data between all groups was somewhat
difficult due to the fact that only one tumor was found in the
19.4% menhaden oil group (Table 6). While 19.4% menhaden oil
group had only one tumor, the 3.9% MO and 15.5%MO:3.9%CO
groups had high numbers of tumors.

It is unknown why the

19.4% CO had the same number of tumors (13) as the 3.9% CO, in
light of published reports that high corn oil diets generally yield
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greater tumor numbers than low corn oil diets. The low-fat corn
oil group, at 2.3% linoleic acid, is below the linoleic acid level (4%)
required for mammary tu morigenesis and the high-fat corn oil
diet, at 11.6 % linoleic acid, is much above this level (7). Therefore,
the higher fat

diet should have produced a significantly higher

number of tumors.

Table 5. Analysis of variance of body weights at time of death.

ss

MS

5

28541

5708

Error

113

42594

377

Total

118

71135

Source

DF

Factor

Fcal 5.14 > Ftab 2.29

MEAN

STD. DEV.

GROUP

N

3.9%CO

19

22 9 ( a)

23.5

3.9%MO

20

231 (a)

23.5

19.4%CO

20

224 (a)

16.5

19.4%MO

20

195 (b)

17.8

15.5 %CO:3. 9 %MO

20

233

16.2

15.5%MO:3.9%CO

20

245

17.5

a significantly different from 15.5%MO:3.9%CO at p<.05.
b significantly different from all groups at p<.o5. ·
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Table 6. Comparison between groups of total tumors, average
tumor number per rat, and tumor number per tumor bearing rat.
Group
tumor

Total
tumors

Average tumor
per group

3.9%CO

13

.68(a)

3.9%MO

23

19.4%CO

13

19.4%MO

1

#

Tumor # per
bearing rat

1.15

1.6
2.1

.75(a)

1.9

.05(a,b)

1.0

15.5%CO:3.9%MO

18

.90

2.0

15.5 %MO:3. 9 %CO

32

1.60

2.7

a significant at p<.05 from 15.5 %MO:3.9%CO.
b significant at p<.05 from 3.9%MO and 15.5%CO:3.9%MO.

Average tumor number per group was significantly lower
in the 19.4% MO group.

Tumor number per tumor-bearing rat

was also much lower in the 19.4% menhaden oil group and highest
in the 3.9% MO and 15.5%MO:3.9%CO groups. These effects in the
3.9% MO group has been observed by several researchers and
implies that additional biochemical features of the lipids must be
involved (22,32).

The effects of mixed dietary ratios of corn oil

and menhaden oil are inconclusive. This research suggests that
the 3. 9 % menhaden oil added to the 15.5 % corn oil does not
suppress tumorigenesis, but that the 3.9% corn oil added to the
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15.5% menhaden oil overcomes the inhibition of 19.4% menhaden
oil alone.
Figures 5 and 6 illustrate total tumor burden per tumorbearing rat per group and average tumor volume per tumorbearing rat, respectively.
difference among the

Although there was no significant

five statistically analyzed groups, in both

figures the obvious difference is the low tumor volumes of the
19.4% menhaden oil group. The average tumor volume per group
in Figure 7 again illustrates this difference.

The general trend

from Figures 5, 6, and 7 is that rats fed diets of either low
menhaden oil alone or high menhaden oil plus low corn oil have
non-significantly elevated tumor data.
Although there was no significant difference among the
comparable groups, there was a noticeable difference in level of
. '

PGE2 in the 19.4% menhaden-oil group (Table 7).

This lower

picogram amount correlates with the findings of the majority of
researchers that a high-fat dietary level of menhaden oil is
effective in depressing tumorigenic activity in induced mammary
tumors through the inhibition of PGE2 synthesis.
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Table 7.

Picograms of prostaglandin E2 per dietary group.

GROUP

PICOGRAMS

STD.DEV.

3.9%CO

6.6

4.2

3.9%MO

6.1

2.2

l 9.4%CO

5.1

2.5

l 9.4%MO

3.8

15.5%CO:3.9%MO

6.7

3.8

15.5%MO:3.9%CO

6.1

2.0

In summary, although the mixed diets proved inconclusive
and that a 3.9% diet of menhaden oil enhanced tumorigenesis, the
obvious conclusion is that a high-fat diet of only menhaden oil
was distinctly effective in inhibiting tumorigenesis.

The exact

mechanism by which this happens is as of yet elusive; however,
these data are supportive of the hypothesis

that the omega-3

fatty acids (EPA and DHA) contained in menhaden oil are
inhibitory to the

enzymes of prostaglandin E2 synthesis.

However, it is possible that the inhibition by 19.4 % menhaden oil
is a result of the lowering of body fat and lack of essential fatty
acids of the n-6 series.

A comparison of body weights, tumor

incidence, and tumor weights showed significant reduction in rats
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menhaden oil compared to the 15.5% menhaden oil/ 3.9% corn oil
group. These reductions may be due to low energy reserves in
the

19.4% rats, a hypothesis that has

been reported

by

Kritchevsky et al. (34).
However, caution must be exerted when evaluating these
benefits for human use. Much more experimentation needs to be
done to evaluate the ratios at which omega-3 fatty acids are
effective. As shown in this study, a low-fat diet of· menhaden oil
and a mixed diet high in menhaden oil were actually stimulato·ry
in their effectiveness in tumorigenesis.
Fish oil capsules now available contain 3 0 0 to 5 0 0
milligrams of omega-3 fatty acids per capsule. Therefore, 15 to
30 capsules must be taken per day to equal the amount used in
many experimental studies.
1130 kJ per day to the diet.

At this dosage, it would add 570 to
If the diet were not adjusted to

accommodate the increase, then a gain of 11 kg of fat tissue would
occur annually. Other adverse side effects would include vitamin
A and D toxicity and vitamin E difficiency.
Superfically, omega-3 fatty acids appear to be a great hope
'for the prevention of dietary fat related cancers. At this moment
the actual benefits versus adverse side effects make any human
use of fish oil a possible hazard. and research is conflicting.
However, with more research and other possible treatments,
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many cancer tragedies through simple dietary modifications may
be prevented.
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